News
Mid-Term review meeting and report
Actually the consortium is preparing the mid-term review meeting and report in order to present the development and results of the ADIBET Project to the European Commission.
The secondments are running
The exchanges of staff that the ADIBET Project planned at the beginning have started to be implemented. Are you interested in a Postdoctoral position? ADIBET consortium offers two recruitments for postdoctoral researchers to start immediately. If you are interested in more information consult the Jobs section and/or contact us.
Job opportunities
Opened the IDIBAPS Postdoctoral position to study the role of the adipose tissue in beta cell function and mass
ADIBET Project is searching a post-doctoral researcher with an experience from 4 to 10 years in order to start a nearly 2 year period in the Diabetes and Obesity Lab in IDIBAPS – Barcelona under the leadership of Prof. Ramon Gomis. Send your application: adibet.idibaps@gmail.com.
Opened the Warwick Postdoctoral position to study the role of the adipose tissue in beta cell function and mass
ADIBET Project is searching a post-doctoral researcher with an experience from 4 to 10 years in order to start a nearly 2 year period in the laboratory of Mike Khan and Stella Pelengaris in the University of Warwick. Send your application: adibet.warwick@gmail.com.
| Home |
ADIBET – The role of adipose tissue in obesity: beta cell crosstalk It is a four year multidisciplinary and intersectorial training programme (2008-2012) that studies the molecular basis of obesity pathophysiology funded by the European Commission. The main aim of this European project is enhance the dynamic pathways between public research organisations and private commercial enterprises, allowing the knowledge and experience sharing between them. The synergies achieved in this project will contribute for the deepening of the beta cell crosstalk with the adipose tissue in obesity. The ADIBET consortium consists of two academic research groups, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and University of Warwick (Warwick), and two SME (Small Medium Enterprises). In this moment one of the SMEs is Genosyst Ltd. and the second one can not be more involved and for that reason then consortium is negotiating the access of a new one with similar characteristics. The international recognition that the academic groups have, assures their high experience mainly in beta cell molecular knowledge, diabetes and obesity. The participating SMEs will give to the consortium the active role necessary to shaping future of Academic Research.
|
